Vasopressin as a rescue vasopressor agent. Treatment of selected cardiogenic shock states;Vasopressin als reservevasopressor. Behandlung ausgewählter kardiogener schockzustände

Anaesthesist

Volumn 56, Issue 10, 2007, Pages 1017-1023

  Mayr, V D ^a   Luckner, G ^a   Jochberger, S ^a   Wenzel, V ^a   Hasibeder, W R ^b   Dunser M W ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Krankenhaus der Barmherzigen Schwestern Ried Betriebsgesellschaft mbH   (Austria)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Arginine vasopressin; Cardiogenic shock; Myocardial infarction; Right cardiac failure; Vasodilatory shock

Indexed keywords

ARGIPRESSIN; HYPERTENSIVE AGENT; VASOPRESSIN;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR EFFECT; CASE REPORT; CRITICALLY ILL PATIENT; FEMALE; HEART INFARCTION; HEART RATE; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPOVOLEMIC SHOCK; LUNG ARTERY PRESSURE; MALE; SEPTIC SHOCK;

AGED; AGED, 80 AND OVER; ARGININE VASOPRESSIN; BLOOD PRESSURE; CRITICAL ILLNESS; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HEART RATE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PULMONARY WEDGE PRESSURE; SEPSIS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 35848960169     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1227-4     Document Type: Article

References (20)

1. Asfar P, Hauser B, Radermacher P, Matejovic M (2006) Catecholamines and vasopressin during critical illness. Crit Care Clin 22: 131-149
2. Bayram M, De Luca L, Massie MB, Gheorghiade M (2005) Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 96: 47-58
3. Braun EB, Palin CA, Hogue CW (2004) Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. Anesth Analg 99: 36-37
4. Dünser MW, Mayr AJ, Ulmer H et al. (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93: 7-13
5. Dünser MW, Mayr AJ, Stallinger A et al. (2002) Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med 28: 746-751
6. Dünser MW, Wenzel V, Mayr AJ, Hasibeder WR (2003) Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 63: 237-256
7. Dünser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107: 2313-2319
8. Dünser MW, Fries DR, Schobersberger W et al. (2004) Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? Anesth Analg 99: 201-206
9. Eichinger MR, Walker BR (1994) Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. Am J Physiol 276: H2413-2419
10. Evora PR, Pearson PJ, Schaff HV (1993) Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 103: 1241-1245
11. Gold JA, Cullinane S, Chen J et al. (2000) Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med 28: 249-252
12. Jolly S, Newton G, Horlick E et al. (2005) Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 96: 1617-1620
13. Landry DW, Levin HR, Gallant EM et al. (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25: 1279-1282
14. Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345: 588-595
15. Leather HA, Segers P, Berends N et al. (2002) Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 30: 2548-2552
16. Luckner G, Dünser MW, Jochberger S et al. (2005) Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 33: 2659-2666
17. Mann HJ, Nolan PE Jr (2006) Update on the management of cardiogenic shock. Curr Opin Crit Care 12: 431-436
18. Mutlu GM, Factor P (2004) Role of vasopressin in the management of septic shock. Intensive Care Med 30: 1276-1291
19. Wang HJ, Wong CS, Chiang CY et al. (2003) Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension: a case report. Acta Anaesthesiol Sin 41: 77-80
20. Westphal M, Stubbe H, Sielenkämper AW et al. (2003) Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 29: 301-308